Therapy of systemic sclerosis

Abstract Views: 922
PDF: 2169
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The treatment of the patient with Systemic Sclerosis has greatly improved in the last ten years, because of two kinds of achievements. A number of drugs have been demonstrated to be active in some disease manifestations like alveolitis, pulmonary hypertension and complicated Raynaud’s phenomenon. Some of these drugs namely cyclophosphamide and iloprost await to be confirmed as disease modifying agents. The methological approach to be made in clinical trials has been defined allowing to correctly analyze the results of published trials and plan future ones.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Valentini, G. (2004). Therapy of systemic sclerosis. Reumatismo, 56(1), 1–8. https://doi.org/10.4081/reumatismo.2004.1